Cidara Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Cidara Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CDTX
Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system.
CEOJeffrey L. Stein
CEOJeffrey L. Stein
Employees38
Employees38
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees38
Employees38
CDTX Key Statistics
Market cap6.89B
Market cap6.89B
Price-Earnings ratio-18.63
Price-Earnings ratio-18.63
Dividend yield—
Dividend yield—
Average volume3.48M
Average volume3.48M
High today$219.90
High today$219.90
Low today$218.86
Low today$218.86
Open price$219.59
Open price$219.59
Volume388.16K
Volume388.16K
52 Week high$220.41
52 Week high$220.41
52 Week low$15.22
52 Week low$15.22
Stock Snapshot
The current Cidara Therapeutics(CDTX) stock price is $219.00, with a market capitalization of 6.89B. The stock trades at a price-to-earnings (P/E) ratio of -18.63.
On 2025-11-21, Cidara Therapeutics(CDTX) stock traded between a low of $218.86 and a high of $219.90. Shares are currently priced at $219.00, which is +0.1% above the low and -0.4% below the high.
Cidara Therapeutics(CDTX) shares are trading with a volume of 388.16K, against a daily average of 3.48M.
In the last year, Cidara Therapeutics(CDTX) shares hit a 52-week high of $220.41 and a 52-week low of $15.22.
In the last year, Cidara Therapeutics(CDTX) shares hit a 52-week high of $220.41 and a 52-week low of $15.22.
Analyst ratings
67%
of 9 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
People also own
Based on the portfolios of people who own CDTX. This list is generated using Robinhood data, and it’s not a recommendation.